Vessix Vascular Completes Its Sale to Boston Scientific Corporation

Stradling represented Vessix Vascular in its acquisition by Boston Scientific Corporation for up to $425 million. Read the press release.

Upon completion of the acquisition, Vessix Vascular became part of the Peripheral Interventions business at Boston Scientific.